AAAAAA
Results:
1-24
|
Results: 24
Authors:
Stebbing, J
Gore, M
Citation: J. Stebbing et M. Gore, The current status of interferon-alpha treatment in advanced renal cancer, BJU INT, 87(7), 2001, pp. 599-601
Authors:
Stebbing, J
Thomas, M
Gore, M
Citation: J. Stebbing et al., Necrosis in melanoma metastases with treatment, ANN ONCOL, 12(6), 2001, pp. 873-874
Authors:
Speake, BK
Surai, PF
Gore, M
Citation: Bk. Speake et al., Lipid composition, fatty acid profiles, and lipid-soluble antioxidants of eggs of the Hermann's tortoise (Testudo hermanni boettgeri), ZOO BIOL, 20(2), 2001, pp. 75-87
Authors:
Short, SC
Traish, D
Dowe, A
Hines, F
Gore, M
Brada, M
Citation: Sc. Short et al., Thalidomide as an anti-angiogenic agent in relapsed gliomas, J NEURO-ONC, 51(1), 2001, pp. 41-45
Authors:
Hollander, J
Fiebig, R
Gore, M
Ookawara, T
Ohno, H
Ji, LL
Citation: J. Hollander et al., Superoxide dismutase gene expression is activated by a single bout of exercise in rat skeletal muscle, PFLUG ARCH, 442(3), 2001, pp. 426-434
Authors:
Cameron, DA
Cornbleet, MC
Mackie, RM
Hunter, JAA
Gore, M
Hancock, B
Smyth, JF
Citation: Da. Cameron et al., Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study, BR J CANC, 84(9), 2001, pp. 1146-1149
Authors:
Gore, M
Rustin, G
Schuller, J
Lane, SR
Hearns, S
Beckman, RA
Ross, G
Citation: M. Gore et al., Topotecan given as a 21-day infusion in the treatment of advanced ovarian cancer, BR J CANC, 84(8), 2001, pp. 1043-1046
Authors:
Khuri, FR
Nemunaitis, J
Ganly, I
Arseneau, J
Tannock, IF
Romel, L
Gore, M
Ironside, J
MacDougall, RH
Heise, C
Randlev, B
Gillenwater, AM
Bruso, P
Kaye, SB
Hong, WK
Kirn, DH
Citation: Fr. Khuri et al., A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer, NAT MED, 6(8), 2000, pp. 879-885
Authors:
Gore, M
Huinink, WT
Carmichael, J
Gordon, A
Davidson, N
Coleman, R
Spaczynski, M
Heron, JF
Bolis, G
Malmstrom, H
Malfetano, J
Scarabelli, C
Vennin, P
Ross, G
Fields, SZ
Citation: M. Gore et al., Clinical evidence for topotecan-paclitaxel non-cross-resistance in ovariancancer, J CL ONCOL, 19(7), 2000, pp. 1893-1900
Authors:
Middleton, MR
Grob, JJ
Aaronson, N
Fierlbeck, G
Tilgen, W
Seiter, S
Gore, M
Aamdal, S
Cebon, J
Coates, A
Dreno, B
Henz, M
Schadendorf, D
Kapp, A
Weiss, J
Fraass, U
Statkevich, P
Muller, M
Thatcher, N
Citation: Mr. Middleton et al., Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma, J CL ONCOL, 18(1), 2000, pp. 158-166
Authors:
Hancock, BW
Harris, S
Wheatley, K
Gore, M
Citation: Bw. Hancock et al., Adjuvant interferon-alpha in malignant melanoma: current status, CANC TR REV, 26(2), 2000, pp. 81-89
Authors:
Bridgewater, J
Gore, M
Citation: J. Bridgewater et M. Gore, Developments in cancer treatment, CANCER NURSING: CARE IN CONTEXT, 2000, pp. 313-333
Authors:
Vaughan, M
Sapunar, F
Gore, M
Citation: M. Vaughan et al., Clinical experience - Platinum and taxanes, CANC DRUG, 7, 2000, pp. 195-230
Authors:
Noe, LL
Becker, RV
Gradishar, WJ
Gore, M
Trotter, JP
Citation: Ll. Noe et al., The cost effectiveness of tamoxifen in the prevention of breast cancer, AM J M CARE, 5(6), 1999, pp. S389-S406
Authors:
Eisenhauer, EA
Gore, M
Neijt, JP
Citation: Ea. Eisenhauer et al., Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?, ANN ONCOL, 10, 1999, pp. 9-15
Authors:
Ozols, RF
Gore, M
Trope, C
Grenman, S
Citation: Rf. Ozols et al., Intraperitoneal treatment and dose-intense therapy in ovarian cancer, ANN ONCOL, 10, 1999, pp. 59-64
Authors:
Berek, JS
Bertelsen, K
du Bois, A
Brady, MF
Carmichael, J
Eisenhauer, EA
Gore, M
Grenman, S
Hamilton, TC
Hansen, SW
Harper, PG
Horvath, G
Kaye, SB
Luck, HJ
Lund, B
McGuire, WP
Neijt, JP
Ozols, RF
Parmar, MKB
Piccart-Gebhart, MJ
van Rijswijk, R
Rosenberg, P
Rustin, GJS
Sessa, C
Thigpen, JT
Trope, C
Tuxen, MK
Vergote, I
Vermorken, JB
Willemse, PHB
Citation: Js. Berek et al., Advanced epithelial ovarian cancer: 1998 consensus statements, ANN ONCOL, 10, 1999, pp. 87-92
Authors:
Hollander, J
Fiebig, R
Gore, M
Bejma, J
Ookawara, T
Ohno, H
Ji, LL
Citation: J. Hollander et al., Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training, AM J P-REG, 46(3), 1999, pp. R856-R862
Authors:
Lu, QX
Gore, M
Zhang, Q
Camenisch, T
Boast, S
Casagranda, F
Lai, C
Skinner, MK
Klein, R
Matsushima, GK
Earp, HS
Goff, SP
Lemke, G
Citation: Qx. Lu et al., Tyro-3 family receptors are essential regulators of mammalian spermatogenesis, NATURE, 398(6729), 1999, pp. 723-728
Authors:
Jefferies, S
Eeles, R
Goldgar, D
A'Hern, R
Henk, JM
Gore, M
Citation: S. Jefferies et al., The role of genetic factors in predisposition to squamous cell cancer of the head and neck, BR J CANC, 79(5-6), 1999, pp. 865-867
Authors:
Stratton, JF
Thompson, D
Bobrow, L
Dalal, N
Gore, M
Bishop, DT
Scott, I
Evans, G
Daly, P
Easton, DF
Ponder, BAJ
Citation: Jf. Stratton et al., The genetic epidemiology of early-onset epithelial ovarian cancer: A population-based study, AM J HU GEN, 65(6), 1999, pp. 1725-1732
Authors:
Ross, G
Malfetano, J
Clarke-Pearson, D
Oza, A
Gore, M
Beckman, R
Fields, S
Lane, S
Dane, G
Citation: G. Ross et al., IV topotecan (TOPT) in patients (Pts) who relapse following platinum(P)/paclitaxel(TX) treatment: subset analysis of a phase III trial, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 285-289
Authors:
Hardy, J
Ling, J
Mansi, J
Isaacs, R
A'Hern, R
Blake, P
Gore, M
Shepherd, J
Hanks, G
Citation: J. Hardy et al., Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction, PALLIAT MED, 12(6), 1998, pp. 437-442
Authors:
Gore, M
Fiebig, R
Hollander, J
Leeuwenburgh, C
Ohno, H
Ji, LL
Citation: M. Gore et al., Endurance training alters antioxidant enzyme gene expression in rat skeletal muscle, CAN J PHYSL, 76(12), 1998, pp. 1139-1145
Risultati:
1-24
|